TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 447
Abstract
The incidence of acute kidney injury (AKI) and chronic kidney disease (CKD) is increasing. However, there is no effective therapy for AKI and current approaches only slow down, but do not prevent progression of CKD. TWEAK is a TNF superfamily cytokine. A solid base of preclinical data suggests a role of therapies targeting the TWEAK or its receptor Fn14 in AKI and CKD. In particular TWEAK/Fn14 targeting may preserve renal function and decrease cell death, inflammation, proteinuria and fibrosis in mouse animal models. Furthermore there is clinical evidence for a role of TWEAK in human kidney injury including increased tissue and/or urinary levels of TWEAK and parenchymal renal cell expression of the receptor Fn14. In this regard, clinical trials of TWEAK targeting are ongoing in lupus nephritis. NF-κB activation plays a key role in TWEAK-elicited inflammatory responses. Activation of the non-canonical NF-κB pathway is a critical difference between TWEAK and TNF. TWEAK activation of the non-canonical NF-κB pathways promotes inflammatory responses in tubular cells. However, there is an incomplete understanding of the role of non-canonical NF-κB activation in kidney disease and on its contribution to TWEAK actions in vivo.Keywords
This publication has 74 references indexed in Scilit:
- NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathwayOncogene, 2011
- NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responsesJournal of Experimental Medicine, 2011
- SMG1 and NIK regulate apoptosis induced by Smac mimetic compoundsCell Death & Disease, 2011
- NF-B-Inducing Kinase Increases Renal Tubule Epithelial Inflammation Associated with DiabetesExperimental Diabetes Research, 2011
- TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFαJournal of Cell Biology, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- Integrating cell-signalling pathways with NF-κB and IKK functionNature Reviews Molecular Cell Biology, 2007
- TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationThe EMBO Journal, 2006
- Cytokine cooperation in renal tubular cell injury: The role of TWEAKKidney International, 2006
- Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosisProceedings of the National Academy of Sciences, 2006